Balance Labs cash‑starved, $0 revenue, heavy related‑party debt; auditors flag going‑concern

Balance Labs, Inc. (PINK: BLNC) - quick read on what's happening inside the company.

Snapshot / What's happening

Management is operating a consulting business with no recorded revenue in the reporting periods. The company is cash‑starved, highly leveraged to related parties, and the independent auditors and management have flagged going‑concern and internal control weaknesses. Management plans to seek additional capital and to begin marketing to add clients, but there is no assurance financing or new clients will materialize.

Key facts & statistics (as reported)

- Cash and cash equivalents: $3,625 (June 30, 2025)

- Marketable securities (investment in NextNRG, related party): $73,607

- Total assets: $77,232

- Total current liabilities: $5,300,886

- Total liabilities: $5,300,886

- Stockholders' deficit / working capital deficiency: $(5,223,654)

- Accumulated deficit: $(6,035,869)

- Shares outstanding: 21,674,000 (as of Aug 14, 2025)

- Revenues: $0 (no reported revenue for the periods)

- Net loss: three months ended June 30, 2025 - $(146,142); six months ended June 30, 2025 - $(152,548)

- Total operating expenses: three months $79,259; six months $158,098

- Salaries & wages (six months): $96,275

- Professional fees (six months): $51,716

- Interest expense (six months, includes amortization of debt discount): $(113,260)

- Unrealized loss on available‑for‑sale securities (six months): $(8,769)

- Gain on settlement of accounts payable (one‑time, six months): $127,579

- Cash used in operating activities (six months): $(57,574)

- Convertible notes payable (long‑term): $525,000

- Related‑party short‑term advances: $1,779,058 (plus accrued related interest $820,452)

- Related‑party accounts payable: $911,659

- Total related‑party notes + accrued interest (schedule): Loans $2,059,100; Accrued interest $1,026,649

Positive aspects of the income statement

- Net loss improved year‑over‑year for six months: $(152,548) in 2025 vs $(217,643) in 2024 - a $65,095 (≈30%) improvement, primarily due to a $127,579 one‑time gain on settlement of accounts payable.

- Company recorded an $8,769 unrealized gain adjustment on its investment in NextNRG for the six months ended June 30, 2025 (investment still carried at $73,607) - shows some mark‑to‑market value in securities held.

Negative aspects of the income statement (and related disclosures)

- No revenue reported for the three‑ and six‑month periods - company has no operating income to cover expenses.

- Operating expenses remain meaningful relative to zero revenue (six‑month operating expenses $158,098) - continued cash burn.

- Heavy interest burden: interest expense ~$113k for six months; interest from related‑party lending also substantial (~$87,820 recognized interest from related‑party notes for six months).

- One‑time gain (settlement of AP $127,579) materially improved six‑month results - improvement is non‑recurring and masks underlying operating losses.

- Going concern: management and independent auditors express substantial doubt about the company's ability to continue for 12 months without new financing.

- Material weaknesses in internal controls: management concluded disclosure controls were not effective (functional controls, no audit committee, inadequate segregation of duties).

Inside risks and immediate issues

- Severe liquidity constraint: $3,625 cash, negative working capital > $5.2M; uses cash in operations and is dependent on related‑party loans and new financing.

- Significant related‑party exposure: CEO and affiliates supplied $1.78M in advances (many in default) and hold large accrued interest balances - this concentration and defaults increase financial risk and governance concerns.

- Multiple notes and convertible debentures in default or past maturity, with large accrued interest (e.g., 16th Avenue Associates convertible note accrual $462,603).

- No independent audit committee oversight and limited staff - raises accounting, governance and operational execution risk.

Bottom line (straightforward)

Balance Labs, Inc. (PINK: BLNC) is a very small consulting company with no reported revenue, shrinking cash, large related‑party financing and a deep stockholders' deficit. The only material improvement in the period was a one‑time payable settlement. Without near‑term financing or a rapid ramp to paying clients, the company faces serious going‑concern risk and potential operational disruption. Investors should treat this as a high‑risk situation driven by liquidity and governance issues rather than operating progress.

Source: Balance Labs, Inc. Form 10‑Q for quarter ended June 30, 2025 (figures reported as presented by the company).